Aimed Bio Inc. (KOSDAQ:0009K0)
South Korea
· Delayed Price · Currency is KRW 65,300
+2,500 (3.98%)
At close: Mar 6, 2026
Aimed Bio Market Cap
Aimed Bio has a market cap or net worth of 4.05 trillion as of March 9, 2026.
Market Cap
4.05T
Enterprise Value
3.89T
Revenue
29.65B
Ranking
n/a
PE Ratio
n/a
Stock Price
65,300.00
Market Cap Chart
Since December 4, 2025, Aimed Bio's market cap has increased from 2.82T to 4.05T, an increase of 43.64%. That is a compound annual growth rate of 320.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 4,223.03B | 14.28% |
| Dec 30, 2025 | 3,695.39B | 30.91% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rznomics | 2,287.94B |
| Qurient | 1,664.89B |
| AprilBio | 1,552.28B |
| JS Link | 1,352.82B |
| Inventage Lab | 1,267.98B |
| ROKIT Healthcare | 1,210.28B |
| Curocell | 763.43B |
| HansBiomed | 695.70B |